GSDMD protects intestinal epithelial cells against bacterial infections through its N-terminal activity affecting intestinal immune homeostasis

Honghui Li , Jie Pu , Dongxue Yang , Lu Liu , Yingchao Hu , Shuo Yang , Bingwei Wang

Journal of Biomedical Research ›› 2024, Vol. 38 ›› Issue (6) : 585 -596.

PDF (5118KB)
Journal of Biomedical Research ›› 2024, Vol. 38 ›› Issue (6) :585 -596. DOI: 10.7555/JBR.38.20240041
Original Article
research-article
GSDMD protects intestinal epithelial cells against bacterial infections through its N-terminal activity affecting intestinal immune homeostasis
Author information +
History +
PDF (5118KB)

Abstract

The intestinal mucosal barrier serves as a vital guardian of the gut health, maintaining a delicate equilibrium between gut microbiota and host immune homeostasis. Gasdermin D (GSDMD), a key executioner of pyroptosis downstream of the inflammasome, has been found to play intricate roles in modulating colitis by influencing intestinal macrophages and regulating mucus secretion from goblet cells. However, the exact nature of the regulatory function of GSDMD in maintaining intestinal immune homeostasis and defending against pathogens remains to be elucidated. In the current study, by using the Citrobacter rodentium infection model, we found that GSDMD played a key role in the defense against intestinal Citrobacter rodentium infection, with high expression levels in intestinal epithelial and lamina propria myeloid cells. Our results showed that GSDMD acted specifically in intestinal epithelial cells to combat the infection, independently of its effects on antimicrobial peptides or mucin secretion. Instead, the resistance was mediated by the N-terminal fragment of GSDMD, highlighting its importance in intestinal immunity. However, the specific mechanism underlying the N-terminal activity of GSDMD in protecting against intestinal bacterial infections requires future investigation.

Keywords

GSDMD / pyroptosis / Citrobacter rodentium infection / intestinal mucosal barrier

Cite this article

Download citation ▾
Honghui Li, Jie Pu, Dongxue Yang, Lu Liu, Yingchao Hu, Shuo Yang, Bingwei Wang. GSDMD protects intestinal epithelial cells against bacterial infections through its N-terminal activity affecting intestinal immune homeostasis. Journal of Biomedical Research, 2024, 38(6): 585-596 DOI:10.7555/JBR.38.20240041

登录浏览全文

4963

注册一个新账户 忘记密码

Fundings

This work was supported by the National Key Research and Development Program of China (Grant No. 2022YFA1303900 to S.Y.), the National Natural Science Foundation of China (Grant Nos. 32270921 and 82070567 to S.Y. and 82204354 to Y.H.), the Open Project of the State Key Laboratory of Reproductive Medicine of Nanjing Medical University (Grant No. SKLRM-2021B3 to S.Y.), the Talent Cultivation Project of "Organized Scientific Research" of Nanjing Medical University (Grant No. NJMURC20220014 to S.Y.), the Natural Science Foundation of Jiangsu Province (Grant No. BK20221352 to B.W.), the Jiangsu Provincial Outstanding Postdoctoral Program (Grant No. 2022ZB419 to Y.H.), the Postdoctoral Research Funding Project of Gusu School (Grant No. GSBSHKY202104 to Y.H.), and the China Postdoctoral Science Foundation (Grant No. 2023T160329 to Y.H.).

Acknowledgments

None.

References

[1]

Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans[J]. Gut, 2019, 68(8): 1516-1526. doi: 10.1136/gutjnl-2019-318427

[2]

Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity[J]. Proc Natl Acad Sci U S A, 2013, 110(22): 9066-9071. doi: 10.1073/pnas.1219451110

[3]

Brown EM, Sadarangani M, Finlay BB. The role of the immune system in governing host-microbe interactions in the intestine[J]. Nat Immunol, 2013, 14(7): 660-667. doi: 10.1038/ni.2611

[4]

Maslov LN, Naryzhnaya NV, Popov SV, et al. A historical literature review of coronary microvascular obstruction and intra-myocardial hemorrhage as functional/structural phenomena[J]. J Biomed Res, 2023, 37(4): 281-302. https://pubmed.ncbi.nlm.nih.gov/37503711/

[5]

Yao X, Zhang C, Xing Y, et al. Remodelling of the gut microbiota by hyperactive NLRP3 induces regulatory T cells to maintain homeostasis[J]. Nat Commun, 2017, 8(1): 1896. doi: 10.1038/s41467-017-01917-2

[6]

Ahn H, Kwon HM, Lee E, et al. Role of inflammasome regulation on immune modulators[J]. J Biomed Res, 2018, 32(5): 401-410.

[7]

Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death[J]. Nature, 2015, 526(7575): 660-665. doi: 10.1038/nature15514

[8]

Hu Y, Wang B, Li S, et al. Pyroptosis, and its role in central nervous system disease[J]. J Mol Biol, 2022, 434(4): 167379. doi: 10.1016/j.jmb.2021.167379

[9]

Naryzhnaya NV, Maslov LN, Popov SV, et al. Pyroptosis is a drug target for prevention of adverse cardiac remodeling: the crosstalk between pyroptosis, apoptosis, and autophagy[J]. J Biomed Res, 2022, 36(6): 375-389. doi: 10.7555/JBR.36.20220123

[10]

Kayagaki N, Stowe IB, Lee BL, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling[J]. Nature, 2015, 526(7575): 666-671. doi: 10.1038/nature15541

[11]

He K, Wan T, Wang D, et al. Gasdermin D licenses MHCII induction to maintain food tolerance in small intestine[J]. Cell, 2023, 186(14): 3033-3048. e20.

[12]

Hu Y, Jiang Y, Li S, et al. The Gasdermin D N-terminal fragment acts as a negative feedback system to inhibit inflammasome-mediated activation of Caspase-1/11[J]. Proc Natl Acad Sci U S A, 2022, 119(45): e2210809119. doi: 10.1073/pnas.2210809119

[13]

Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation[J]. Cell, 2014, 157(1): 121-141. doi: 10.1016/j.cell.2014.03.011

[14]

Hotchkiss RS, Moldawer LL, Opal SM, et al. Sepsis and septic shock[J]. Nat Rev Dis Primers, 2016, 2: 16045. doi: 10.1038/nrdp.2016.45

[15]

Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes[J]. J Clin Invest, 2005, 115(5): 1111-1119. doi: 10.1172/JCI25102

[16]

Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease[J]. Circ Res, 2005, 96(9): 939-949. doi: 10.1161/01.RES.0000163635.62927.34

[17]

Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology[J]. Lancet, 2007, 369(9573): 1627-1640. doi: 10.1016/S0140-6736(07)60750-8

[18]

Glass CK, Saijo K, Winner B, et al. Mechanisms underlying inflammation in neurodegeneration[J]. Cell, 2010, 140(6): 918-934. doi: 10.1016/j.cell.2010.02.016

[19]

Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences[J]. Immunity, 2019, 51(1): 27-41. doi: 10.1016/j.immuni.2019.06.025

[20]

Wang B, Ma Y, Li S, et al. GSDMD in peripheral myeloid cells regulates microglial immune training and neuroinflammation in Parkinson's disease[J]. Acta Pharm Sin B, 2023, 13(6): 2663-2679. doi: 10.1016/j.apsb.2023.04.008

[21]

Li S, Wu Y, Yang D, et al. Gasdermin D in peripheral myeloid cells drives neuroinflammation in experimental autoimmune encephalomyelitis[J]. J Exp Med, 2019, 216(11): 2562-2581. doi: 10.1084/jem.20190377

[22]

Jiang Y, Yang Y, Hu Y, et al. Gasdermin D restricts anti-tumor immunity during PD-L1 checkpoint blockade[J]. Cell Rep, 2022, 41(4): 111553. doi: 10.1016/j.celrep.2022.111553

[23]

He W, Shi X, Dong Z. The roles of RACK1 in the pathogenesis of Alzheimer's disease[J]. J Biomed Res, 2024, 38(2): 137-148. https://pubmed.ncbi.nlm.nih.gov/38410996/

[24]

Zhang J, Yu Q, Jiang D, et al. Epithelial Gasdermin D shapes the host-microbial interface by driving mucus layer formation[J]. Sci Immunol, 2022, 7(68): eabk2092. doi: 10.1126/sciimmunol.abk2092

[25]

Ma C, Yang D, Wang B, et al. Gasdermin D in macrophages restrains colitis by controlling cGAS-mediated inflammation[J]. Sci Adv, 2020, 6(21): eaaz6717. doi: 10.1126/sciadv.aaz6717

[26]

Jiang Y, Ma C, Hu Y, et al. ECSIT is a Critical factor for controlling intestinal homeostasis and tumorigenesis through regulating the translation of YAP protein[J]. Adv Sci (Weinh), 2023, 10(25): 2205180. doi: 10.1002/advs.202205180

[27]

Song-Zhao GX, Srinivasan N, Pott J, et al. Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen[J]. Mucosal Immunol, 2014, 7(4): 763-774. doi: 10.1038/mi.2013.94

[28]

Ashida H, Ogawa M, Kim M, et al. Bacteria and host interactions in the gut epithelial barrier[J]. Nat Chem Biol, 2012, 8(1): 36-45. doi: 10.1038/nchembio.741

[29]

Sborgi L, Ruhl S, Mulvihill E, et al. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death[J]. EMBOJ, 2016, 35(16): 1766-1778. doi: 10.15252/embj.201694696

[30]

Zheng D, Liwinski T, Elinav E. Inflammasome activation and regulation: toward a better understanding of complex mechanisms[J]. Cell Discov, 2020, 6: 36. doi: 10.1038/s41421-020-0167-x

[31]

Schwarzer R, Jiao H, Wachsmuth L, et al. FADD and caspase-8 regulate gut homeostasis and inflammation by controlling MLKL- and GSDMD-mediated death of intestinal epithelial cells[J]. Immunity, 2020, 52(6): 978-993. e6.

[32]

Scott SA, Fu J, Chang PV. Dopamine receptor D2 confers colonization resistance via microbial metabolites[J]. Nature, 2024, 628(8006): 180-185. doi: 10.1038/s41586-024-07179-5

[33]

Miao R, Jiang C, Chang WY, et al. Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis[J]. Immunity, 2023, 56(11): 2523-2541.e8.

PDF (5118KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/